Heat-stable carbetocin is a synthetic oxytocin analogue designed to prevent postpartum hemorrhage (PPH) in women after childbirth, particularly in settings where cold storage is limited. Unlike oxytocin, which requires refrigeration, heat-stable carbetocin can remain effective even when stored at higher temperatures, making it ideal for use in low-resource or tropical environments. This stability enhances its accessibility in regions where maintaining the cold chain for medications is challenging.
The global Heat Stable Carbetocin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Heat Stable Carbetocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heat Stable Carbetocin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heat Stable Carbetocin include Ferring Pharmaceuticals, Alembic Pharmaceuticals, Abbott, SGPharma, Incepta Pharmaceuticals, Taj Pharma, Chengdu Shengnuo Biotechnology, Suzhou Tianma Pharmaceutical, Suzhou Erye Pharmaceutica, Hainan Zhonghe Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heat Stable Carbetocin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heat Stable Carbetocin.
The Heat Stable Carbetocin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Heat Stable Carbetocin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heat Stable Carbetocin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ferring Pharmaceuticals
Alembic Pharmaceuticals
Abbott
SGPharma
Incepta Pharmaceuticals
Taj Pharma
Chengdu Shengnuo Biotechnology
Suzhou Tianma Pharmaceutical
Suzhou Erye Pharmaceutica
Hainan Zhonghe Pharmaceutical
PolyPeptide Laboratories
Cisen Pharmaceutical
Hangzhou Ausia Biological Technology
Xingyin Pharmaceutical
Hybio Pharmaceutical
Chengdu Leer Pharmaceutical
Segment by Type
Intravenous Injection
Intramuscular Injection
Segment by Application
Postpartum Hemorrhage
Uterine Atony
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heat Stable Carbetocin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heat Stable Carbetocin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Heat Stable Carbetocin Market Overview
1.1 Product Definition
1.2 Heat Stable Carbetocin by Type
1.2.1 Global Heat Stable Carbetocin Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous Injection
1.2.3 Intramuscular Injection
1.3 Heat Stable Carbetocin by Application
1.3.1 Global Heat Stable Carbetocin Market Value by Application (2024-2030)
1.3.2 Postpartum Hemorrhage
1.3.3 Uterine Atony
1.3.4 Other
1.4 Global Heat Stable Carbetocin Market Size Estimates and Forecasts
1.4.1 Global Heat Stable Carbetocin Revenue 2019-2030
1.4.2 Global Heat Stable Carbetocin Sales 2019-2030
1.4.3 Global Heat Stable Carbetocin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heat Stable Carbetocin Market Competition by Manufacturers
2.1 Global Heat Stable Carbetocin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heat Stable Carbetocin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heat Stable Carbetocin Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Heat Stable Carbetocin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heat Stable Carbetocin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heat Stable Carbetocin, Product Type & Application
2.7 Global Key Manufacturers of Heat Stable Carbetocin, Date of Enter into This Industry
2.8 Global Heat Stable Carbetocin Market Competitive Situation and Trends
2.8.1 Global Heat Stable Carbetocin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Heat Stable Carbetocin Players Market Share by Revenue
2.8.3 Global Heat Stable Carbetocin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heat Stable Carbetocin Market Scenario by Region
3.1 Global Heat Stable Carbetocin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heat Stable Carbetocin Sales by Region: 2019-2030
3.2.1 Global Heat Stable Carbetocin Sales by Region: 2019-2024
3.2.2 Global Heat Stable Carbetocin Sales by Region: 2025-2030
3.3 Global Heat Stable Carbetocin Revenue by Region: 2019-2030
3.3.1 Global Heat Stable Carbetocin Revenue by Region: 2019-2024
3.3.2 Global Heat Stable Carbetocin Revenue by Region: 2025-2030
3.4 North America Heat Stable Carbetocin Market Facts & Figures by Country
3.4.1 North America Heat Stable Carbetocin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heat Stable Carbetocin Sales by Country (2019-2030)
3.4.3 North America Heat Stable Carbetocin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heat Stable Carbetocin Market Facts & Figures by Country
3.5.1 Europe Heat Stable Carbetocin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heat Stable Carbetocin Sales by Country (2019-2030)
3.5.3 Europe Heat Stable Carbetocin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heat Stable Carbetocin Market Facts & Figures by Region
3.6.1 Asia Pacific Heat Stable Carbetocin Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heat Stable Carbetocin Sales by Region (2019-2030)
3.6.3 Asia Pacific Heat Stable Carbetocin Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Heat Stable Carbetocin Market Facts & Figures by Country
3.7.1 Latin America Heat Stable Carbetocin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heat Stable Carbetocin Sales by Country (2019-2030)
3.7.3 Latin America Heat Stable Carbetocin Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Heat Stable Carbetocin Market Facts & Figures by Country
3.8.1 Middle East and Africa Heat Stable Carbetocin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heat Stable Carbetocin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heat Stable Carbetocin Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heat Stable Carbetocin Sales by Type (2019-2030)
4.1.1 Global Heat Stable Carbetocin Sales by Type (2019-2024)
4.1.2 Global Heat Stable Carbetocin Sales by Type (2025-2030)
4.1.3 Global Heat Stable Carbetocin Sales Market Share by Type (2019-2030)
4.2 Global Heat Stable Carbetocin Revenue by Type (2019-2030)
4.2.1 Global Heat Stable Carbetocin Revenue by Type (2019-2024)
4.2.2 Global Heat Stable Carbetocin Revenue by Type (2025-2030)
4.2.3 Global Heat Stable Carbetocin Revenue Market Share by Type (2019-2030)
4.3 Global Heat Stable Carbetocin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heat Stable Carbetocin Sales by Application (2019-2030)
5.1.1 Global Heat Stable Carbetocin Sales by Application (2019-2024)
5.1.2 Global Heat Stable Carbetocin Sales by Application (2025-2030)
5.1.3 Global Heat Stable Carbetocin Sales Market Share by Application (2019-2030)
5.2 Global Heat Stable Carbetocin Revenue by Application (2019-2030)
5.2.1 Global Heat Stable Carbetocin Revenue by Application (2019-2024)
5.2.2 Global Heat Stable Carbetocin Revenue by Application (2025-2030)
5.2.3 Global Heat Stable Carbetocin Revenue Market Share by Application (2019-2030)
5.3 Global Heat Stable Carbetocin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Company Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ferring Pharmaceuticals Heat Stable Carbetocin Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 Alembic Pharmaceuticals
6.2.1 Alembic Pharmaceuticals Company Information
6.2.2 Alembic Pharmaceuticals Description and Business Overview
6.2.3 Alembic Pharmaceuticals Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alembic Pharmaceuticals Heat Stable Carbetocin Product Portfolio
6.2.5 Alembic Pharmaceuticals Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Heat Stable Carbetocin Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 SGPharma
6.4.1 SGPharma Company Information
6.4.2 SGPharma Description and Business Overview
6.4.3 SGPharma Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SGPharma Heat Stable Carbetocin Product Portfolio
6.4.5 SGPharma Recent Developments/Updates
6.5 Incepta Pharmaceuticals
6.5.1 Incepta Pharmaceuticals Company Information
6.5.2 Incepta Pharmaceuticals Description and Business Overview
6.5.3 Incepta Pharmaceuticals Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Incepta Pharmaceuticals Heat Stable Carbetocin Product Portfolio
6.5.5 Incepta Pharmaceuticals Recent Developments/Updates
6.6 Taj Pharma
6.6.1 Taj Pharma Company Information
6.6.2 Taj Pharma Description and Business Overview
6.6.3 Taj Pharma Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Taj Pharma Heat Stable Carbetocin Product Portfolio
6.6.5 Taj Pharma Recent Developments/Updates
6.7 Chengdu Shengnuo Biotechnology
6.7.1 Chengdu Shengnuo Biotechnology Company Information
6.7.2 Chengdu Shengnuo Biotechnology Description and Business Overview
6.7.3 Chengdu Shengnuo Biotechnology Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chengdu Shengnuo Biotechnology Heat Stable Carbetocin Product Portfolio
6.7.5 Chengdu Shengnuo Biotechnology Recent Developments/Updates
6.8 Suzhou Tianma Pharmaceutical
6.8.1 Suzhou Tianma Pharmaceutical Company Information
6.8.2 Suzhou Tianma Pharmaceutical Description and Business Overview
6.8.3 Suzhou Tianma Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Suzhou Tianma Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.8.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates
6.9 Suzhou Erye Pharmaceutica
6.9.1 Suzhou Erye Pharmaceutica Company Information
6.9.2 Suzhou Erye Pharmaceutica Description and Business Overview
6.9.3 Suzhou Erye Pharmaceutica Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Suzhou Erye Pharmaceutica Heat Stable Carbetocin Product Portfolio
6.9.5 Suzhou Erye Pharmaceutica Recent Developments/Updates
6.10 Hainan Zhonghe Pharmaceutical
6.10.1 Hainan Zhonghe Pharmaceutical Company Information
6.10.2 Hainan Zhonghe Pharmaceutical Description and Business Overview
6.10.3 Hainan Zhonghe Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hainan Zhonghe Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.10.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
6.11 PolyPeptide Laboratories
6.11.1 PolyPeptide Laboratories Company Information
6.11.2 PolyPeptide Laboratories Description and Business Overview
6.11.3 PolyPeptide Laboratories Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 PolyPeptide Laboratories Heat Stable Carbetocin Product Portfolio
6.11.5 PolyPeptide Laboratories Recent Developments/Updates
6.12 Cisen Pharmaceutical
6.12.1 Cisen Pharmaceutical Company Information
6.12.2 Cisen Pharmaceutical Description and Business Overview
6.12.3 Cisen Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cisen Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.12.5 Cisen Pharmaceutical Recent Developments/Updates
6.13 Hangzhou Ausia Biological Technology
6.13.1 Hangzhou Ausia Biological Technology Company Information
6.13.2 Hangzhou Ausia Biological Technology Description and Business Overview
6.13.3 Hangzhou Ausia Biological Technology Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hangzhou Ausia Biological Technology Heat Stable Carbetocin Product Portfolio
6.13.5 Hangzhou Ausia Biological Technology Recent Developments/Updates
6.14 Xingyin Pharmaceutical
6.14.1 Xingyin Pharmaceutical Company Information
6.14.2 Xingyin Pharmaceutical Description and Business Overview
6.14.3 Xingyin Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Xingyin Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.14.5 Xingyin Pharmaceutical Recent Developments/Updates
6.15 Hybio Pharmaceutical
6.15.1 Hybio Pharmaceutical Company Information
6.15.2 Hybio Pharmaceutical Description and Business Overview
6.15.3 Hybio Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hybio Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.15.5 Hybio Pharmaceutical Recent Developments/Updates
6.16 Chengdu Leer Pharmaceutical
6.16.1 Chengdu Leer Pharmaceutical Company Information
6.16.2 Chengdu Leer Pharmaceutical Description and Business Overview
6.16.3 Chengdu Leer Pharmaceutical Heat Stable Carbetocin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chengdu Leer Pharmaceutical Heat Stable Carbetocin Product Portfolio
6.16.5 Chengdu Leer Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heat Stable Carbetocin Industry Chain Analysis
7.2 Heat Stable Carbetocin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heat Stable Carbetocin Production Mode & Process
7.4 Heat Stable Carbetocin Sales and Marketing
7.4.1 Heat Stable Carbetocin Sales Channels
7.4.2 Heat Stable Carbetocin Distributors
7.5 Heat Stable Carbetocin Customers
8 Heat Stable Carbetocin Market Dynamics
8.1 Heat Stable Carbetocin Industry Trends
8.2 Heat Stable Carbetocin Market Drivers
8.3 Heat Stable Carbetocin Market Challenges
8.4 Heat Stable Carbetocin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Ferring Pharmaceuticals
Alembic Pharmaceuticals
Abbott
SGPharma
Incepta Pharmaceuticals
Taj Pharma
Chengdu Shengnuo Biotechnology
Suzhou Tianma Pharmaceutical
Suzhou Erye Pharmaceutica
Hainan Zhonghe Pharmaceutical
PolyPeptide Laboratories
Cisen Pharmaceutical
Hangzhou Ausia Biological Technology
Xingyin Pharmaceutical
Hybio Pharmaceutical
Chengdu Leer Pharmaceutical
听
听
*If Applicable.